Chemosensitizing interactions of clofazimine and B669 with human K562 erythroleukaemia cells with varying levels of expression of P-glycoprotein

Cancer Letters

Volumn 99, Issue 1, 1996, Pages 73-78

  Myer, Martin S ^a   Van Rensburg, Constance E J ^a  

^a UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

B669; Clofazimine; K562 P subclones; Multidrug resistance

Indexed keywords

3 ANILINO 2 CYCLOHEXYLIMINO 2,10 DIHYDRO 10 PHENYLPHENAZINE; CLOFAZIMINE; DAUNORUBICIN; DOXORUBICIN; GLYCOPROTEIN P; VINBLASTINE;

ARTICLE; CELL CLONE; CELL STRAIN K 562; CHEMOSENSITIVITY; ERYTHROLEUKEMIA; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; PRIORITY JOURNAL;

EID: 0030048891     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3835(95)04039-0     Document Type: Article

References (19)

1. Ferry, D.R. and Kerr, D.J. (1994) Multidrug resistance in cancer. Br. Med. J., 308, 148-149.
2. Gottesman, M.M. and Pastan, I. (1993) Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem., 62, 385-427.
3. Cole, S.P.C., Bhardwaj, G., Gerlach, J.H., MacKie, J.E., Grant, C.E., Almquist, K.C., Stewart, A.J., Kurz, E.U., Duncan, A.M.V. and Deeley, R.G. (1992) Overexpression of a novel transporter gene in a multidrug resistant human lung cancer cell line. Science, 258, 1650-1654.
4. Okabe-Kado, J., Hayashi, M., Honma, Y., Hozumi, M. and Tsuruo, T. (1991) Inhibition of erythroid differentiation factor (activin A) of P-glycoprotein expression in multidrug-resistant human K562 erythroleukemia cells. Cancer Res., 51, 2582-2586.
5. Van Rensburg, C.E.J., Anderson, R., Myer, M.S., Jooné, G.K. and O'Sullivan, J.F. (1994) The riminophenazine agents clofazimine and B669 reverse acquired multidrug resistance in a human lung cancer cell line. Cancer Lett., 85, 59-63.
6. Kawamoto, T., Sato, J.D., Le. A., McClure, D.M. and Sato, G.H. (1983) Development of a serum-free medium for growth of NS-1 mouse myeloma cells and its application to the isolation of NS-1 hybridomas. Anal. Biochem., 130, 445-453.
7. Lozzio, C.B. and Lozzio, B.B. (1975) Human chronic myelogenous leukemia cell line with positive Philadelphia chromosome. Blood, 45, 321-334.
8. Marks, D.C., Davey, M.W., Davey, R.A. and Kidman, A.D. (1993) Differentiation and multidrug resistance in response to drug treatment in the K562 human leukaemia cell line. Br. J. Haematol., 84, 83-89.
9. Hamada, H. and Tsuruo, T. (1986) Functional role for the 170-180 kDa glycoprotein specific to drug resistant tumor cells as revealed by monoclonal antibodies. Proc. Natl. Acad Sci. USA, 83, 7785-7789.
10. Mosmann, T. (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods, 65, 55.
11. Coley, H.M. Twentyman, P.R. and Workman, P. (1989) Improved cellular accumulation is characteristic of anthracyclines which retain high activity in multidrug resistant cell lines, alone or in combination with verapamil or cyclosporin A. Biochem. Pharmacol., 38, 4467-4475.
12. Marie, J., Zittoun, R. and Sikic, B. (1991) Multidrug resistance (MDR 1) gene expression in adult acute leukemias: correlation with treatment outcome and in vitro drug sensitivity. Blood, 78, 586-592.
13. Hamada, H., Hagiwara, K.-I., Nakajima, T. and Tsuruo, T. (1987) Phosphorylation of the Mr 170 000 to 180 000 glycoprotein specific to multidrug-resistant tumour cells: effects of verapamil, trifluoperazine and phorbol esters. Cancer Pres., 47, 2860-2865.
14. Chaudhary, P.M. and Roninson, I. (1991) Expression and activity of P-glycoprotein, a multidrug efflux pump in human hematopoeitic stem cells. Cell, 66, 85-94.
15. Campos, L., Guyotat, D., Archimbaud, E., Calmard-Oriol, P., Tsuruo, T., Troncy, J., Trielle, D. and Fiere, D. (1992) Clinical significance of multidrug resistance P-glycoprotein expression on acute nonlymphocytic leukemia cells at diagnosis. Blood, 79, 473-476.
16. Choi, K., Frommel, T.O., Kaplan Stern, R., Perez, C.F., Kriegler, M., Tsuruo, T. and Roninson, I.B. (1991) Multidrug resistance after retroviral transfer of the human MDR 1 gene correlates with P-glycoprotein density in the plasma membrane and is not affected by cytotoxic selection. Proc. Natl. Acad. Sci. USA, 88, 7386-7390.
17. Jiang, X.-R., Kelsey, S.M., Wu, Y.-L. and Newland, A.C. (1995) Circumvention of P-glycoprotein-mediated drug resistance in human leukaemic cells by non-immuno-suppressive cyclosporin D analogue, SDZ PSC 833. Br. J. Haematol., 90, 375-383.
18. Dean, N.H., Kanemitsu, M. and Boynton, A.L. (1989) Effects of the tyrosine-kinase inhibitor genistein on DNA synthesis and phospholipid-derived second messenger generation in mouse 10T1/2 fibroblasts and rat liver TS1B cells. Biochem. Biophys. Res. Commun., 165, 795-801.
19. Versantvoort, C.H.M., Broxterman, H.J., Bagrij, T. and Twentyman, P.R. (1994) Reversal of drug resistance in MRP overexpressing multidrug resistant human lung tumor cells. Anti-Cancer Drugs, 5 (Suppl. 1), 30.